Search Results - Geoffrey Chong

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma by Genevieve Douglas, Zoe Loh, Evonne S.Y. Shum, Sze-Ting Lee, Niamh Waters, Garry Hamilton, Geoffrey Chong, Alexandra C. Murphy, Eliza A. Hawkes

    Published in Blood Advances (2025-02-01)
    Get full text
    Article


  2. 2

    Opportunistic bone density assessment using pre-treatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy by Genevieve Douglas, Kane M. Nicholls, Erin Paul, Zoe Loh, Sze-Ting Lee, Kathryn L Hackman, Cherie Chiang, Niamh Waters, Geoffrey Chong, Ashvind Prabahran, Eliza A. Hawkes

    Published in Haematologica (2025-01-01)
    Get full text
    Article


  3. 3

    Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study by Eliza Chung, Luke Wang, Cameron Wellard, Allison Barraclough, Belinda A. Campbell, Geoffrey Chong, Pietro Di Ciaccio, Gareth P. Gregory, Greg Hapgood, Anna M. Johnston, Constantine S. Tam, Stephen Opat, Erica M. Wood, Zoe K. McQuilten, Eliza A. Hawkes

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  4. 4

    Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review by Luke Wang, Eliza Chung, Cameron Wellard, Allison Barraclough, Belinda A. Campbell, Geoffrey Chong, Pietro R. Di Ciaccio, Gareth P. Gregory, Greg Hapgood, Anna M. Johnston, Constantine Tam, Stephen Opat, Erica M. Wood, Zoe K. McQuilten, Eliza A. Hawkes

    Published in Blood Advances (2025-05-01)
    Get full text
    Article


  5. 5

    T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial by Eliza A. Hawkes, Jodie B. Palmer, Richard Khor, Sze Ting Lee, Melinda Burgess, Soi C. Law, Maher K. Gandhi, Geoffrey Chong, Jake Shortt, Rakin Chowdhury, Fiona Swain, Leonid Churilov, Michael MacManus, Charmaine Smith, Fiona E. Scott, Arina Martynchyk, Allison Barraclough, Kate Manos, Andrew M. Scott, Colm Keane

    Published in Blood Advances (2025-10-01)
    Get full text
    Article


  6. 6

    Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A. Hawkes

    Published in eJHaem (2024-04-01)
    Get full text
    Article


  7. 7

    Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study by Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, Geoffrey Chong, Edward Yoo, Chan Y. Cheah, Nunzio Franco, Bianca Nguyen, Howard Mutsando, Fatima Tahir, Judith Trotman, Jing Huang, Colm Keane, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, Stephen Opat, Zoe K. McQuilten, Erica M. Wood, Gayathri St George, Eliza A. Hawkes

    Published in Haematologica (2024-03-01)
    Get full text
    Article


Search Tools: